Moreover, CCNB2 had been identified as a marker of responsiveness to immune checkpoint inhibitors (ICI) in NSCLC and overexpression of CCNB2 is a poor prognostic indicator in Chinese patients with NSCLC [52, 53]. The gene discussed is CCNB2; the disease is non-small cell lung carcinoma.